Skip to content

Investigating of the effect of the metacognitive therapy-based program on meta-worry, sense of coherence, and meaning in life in patients with diabetic foot ulcers referrer to selected treatment centers in Isfahan 2025-2026

Investigating of the effect of the metacognitive therapy-based program on meta-worry, sense of coherence, and meaning in life in patients with diabetic foot ulcers referrer to selected treatment centers in Isfahan 2025-2026

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20260215068873N1
Enrollment
64
Registered
2026-04-29
Start date
2026-05-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer. Type 2 diabetes mellitus with foot ulcer

Interventions

Intervention 1: Intervention group: In this study, the metacognitive program consists of 6 group sessions twice a week (each session lasts about 6 minutes). The session titles include: initial introdu

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The samples are diagnosed with diabetic foot ulcers by a doctor and have a medical record in selected treatment centers in Isfahan, and they referred to these centers. The samples should be at levels 1, 2, 3, 4, and 5 according to the Wagner classification for grading the severity of diabetic foot ulcers. The samples must have interest, willingness, and full informed consent to cooperate in the study. Examples that have the ability to communicate verbally and speak Persian. The samples should not have participated in another similar educational or research program simultaneously or recently. The samples have a stable medical condition (no need for hospitalization or immediate surgery). Do not have a current acute mental disorder that would lead to medication use. Be over 18 years of age. Must have at least some education, meaning literacy. Have the physical and mental ability to participate in the study. Do not have any other concurrent illness Have not had recent acute stress, such as divorce

Exclusion criteria

Exclusion criteria: The sample does not wish to continue participating in the study. Severe change in medical condition or hospitalization during the study that prevents attendance at meetings or follow-up. The sample is absent from two or more training sessions.

Design outcomes

Primary

MeasureTime frame
Meta-worry refers to the secondary beliefs and concerns that a person has about their worry process; that is, the person not only worries about external events but also worries about their own worries. Timepoint: Before, immediately and one month after the intervention. Method of measurement: Meta-Worry Questionnaire; MWQ.;It is a concept first introduced by Antonovsky and refers to an individual's overall perception of the world as an understandable, manageable, and meaningful environment. This means that the individual sees life events as orderly and predictable, relies on internal and external resources to cope with challenges, and sees everyday activities and experiences as having value and purpose. Timepoint: Before, immediately and one month after the intervention. Method of measurement: Sense of Coherence Scale – 13 Item Version.;Meaning in life refers to a person's sense of purpose, significance, and overall coherence in life and is positively associated with mental health, hope, and subjective well-being. This construct typically includes two main dimensions: meaning-seeking and meaning-seeking. Meaning-seeking refers to a person's sense of having purpose and value in life, and meaning-seeking refers to the effort to find or deepen these purposes and values. Timepoint: Before, immediately and one month after the intervention. Method of measurement: Meaning in Life Questionnaire; MLQ.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Lohrasebi Nejad

Esfahan University of Medical Sciences

Flohrasebi@nm.mui.ac.ir+98 31 3792 7607

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026